期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Hepatic schwannoma:Imaging findings on CT,MRI and contrast-enhanced ultrasonography 被引量:12
1
作者 Yu Ota Kazunobu Aso +12 位作者 Kenji Watanabe Takahiro Einama koji imai Hidenori Karasaki Ryuji Sudo Yosui Tamaki Mituyoshi Okada Yosihiko Tokusashi Toru Kono Naoyuki Miyokawa Masakazu Haneda Masahiko Taniguchi Hiroyuki Furukawa 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第35期4967-4972,共6页
A primary benign schwannoma of the liver is extremely rare and is difficult to preoperatively discriminate from a malignant tumor.We compared the imaging and pathological findings,and examined the possibility of preop... A primary benign schwannoma of the liver is extremely rare and is difficult to preoperatively discriminate from a malignant tumor.We compared the imaging and pathological findings,and examined the possibility of preoperatively diagnosing a benign liver schwannoma.A 72-year-old woman was admitted to our hospital because of a 4.6-cm mass in the liver.A malignant tumor was suspected,and a right hepatectomy was performed.After this,the diagnosis of a primary benign schwannoma of the liver was made through pathological examination.Contrast-enhanced ultrasonography(CEUS) with Sonazoid showed minute blood flows into the septum and solid areas of the tumor in the vascular phase;most likely due to increased arterial flow associated with infiltration of chronic inflammatory cells.In the postvascular phase,CEUS showed contrast defect of cystic areas and delayed enhancement of solid areas;most likely due to aggregation of siderophores.Because discriminating between a benign and malignant schwannoma of the liver is difficult,surgery is generally recommended.However,the two key findings from CEUS may be useful in discriminating ancient schwannoma by recognizing the hemorrhage involved in the secondary degeneration and aggregation of siderophores. 展开更多
关键词 肝脏 神经 造影 超声 影像学 MRI CT 病理检查
下载PDF
Hepatic clearance measured with ^(99m)Tc-GSA single-photon emission computed tomography to estimate liver fibrosis 被引量:12
2
作者 Masahiko Taniguchi Atsutaka Okizaki +6 位作者 Kenji Watanabe koji imai Koichiro Uchida Takahiro Einama Noriyuki Shuke Naoyuki Miyokawa Hiroyuki Furukawa 《World Journal of Gastroenterology》 SCIE CAS 2014年第44期16714-16720,共7页
AIM: To evaluate the clinical utility of hepatic clearance(HC) measured with technetium-99m-diethylenetriaminepenta-acetic acid-galactosyl human serum albumin(99mTc-GSA) single-photon emission computed tomography(SPEC... AIM: To evaluate the clinical utility of hepatic clearance(HC) measured with technetium-99m-diethylenetriaminepenta-acetic acid-galactosyl human serum albumin(99mTc-GSA) single-photon emission computed tomography(SPECT) to estimate the degree of liver fibrosis.METHODS:Seventy-eight consecutive patients who underwent initial hepatectomy due to hepatocellular carcinoma were enrolled in this study.Indocyanine green clearance(ICG R15),quantitative indices estimated by 99mTc-GSA[the receptor index(LHL15 and HH15)and HC via SPECT analysis],and conventional liver function tests were performed before hepatectomy.Correlations among the quantitative indices for liver functional reserve,conventional liver function tests,andthe degree of liver fibrosis were evaluated.RESULTS:The degree of liver fibrosis was correlated with ICG R15,HH15,LHL15,and HC.HC showed the best correlation with conventional liver function tests.According to multivariate analysis,HC and LHL15 were significant independent predictors of severe fibrosis.HC was the most valuable index for predicting severe fibrosis.CONCLUSION:HC measured with 99mTc-GSA SPECT is a reliable index for assessing liver fibrosis before hepatectomy. 展开更多
关键词 FIBROSIS Technetium-99m-diethylenetri-aminepenta-a
下载PDF
Successful hepatic resection for recurrent hepatocellular carcinoma after lenvatinib treatment:A case report 被引量:1
3
作者 Hideki Yokoo Hiroyuki Takahashi +5 位作者 Masahiro Hagiwara Hiroyoshi Iwata koji imai Yoshinori Saito NaotoMatsuno Hiroyuki Furukawa 《World Journal of Hepatology》 2020年第12期1349-1357,共9页
BACKGROUND Lenvatinib has been shown to be noninferior to sorafenib regarding prognosis and recurrence rate in patients with unresectable hepatocellular carcinoma(HCC)who have not received prior systemic chemotherapy.... BACKGROUND Lenvatinib has been shown to be noninferior to sorafenib regarding prognosis and recurrence rate in patients with unresectable hepatocellular carcinoma(HCC)who have not received prior systemic chemotherapy.In patients treated with lenvatinib,40%of cases achieved sufficient tumor reduction to make potential surgery possible.However,the outcomes of such surgery are unknown.We report a successful case of hepatic resection for recurrent HCC after lenvatinib treatment.CASE SUMMARY A 69-year-old man underwent right anterior sectionectomy for HCC in segment 8 of the liver.Ten months later,he was found to have an intrahepatic HCC recurrence that grew rapidly to 10 cm in diameter with sternal bone metastases.After confirming partial response to lenvatinib administration for 2 mo,a second hepatectomy was performed.Pathological examination showed that 80%of the tumor was necrotic.The patient did not develop any adverse effects under lenvatinib treatment.He was discharged at 25 d after surgery.Radiation therapy for bone metastases continued to be given under lenvatinib,and the patient has remained alive for 1 year after the second hepatectomy.CONCLUSION The prognosis of patients with recurrent HCC may be improved by liver resection combined with prior lenvatinib therapy. 展开更多
关键词 Conversion to surgery Lenvatinib Recurrent hepatocellular carcinoma Case report Neoadjuvant therapy Molecular targeted therapy
下载PDF
Long-term growth of intrahepatic papillary neoplasms: A case report
4
作者 Takumu Hasebe koji Sawada +8 位作者 Hidemi Hayashi Shunsuke Nakajima Hiroyuki Takahashi Masahiro Hagiwara koji imai Sayaka Yuzawa Mikihiro Fujiya Hiroyuki Furukawa Toshikatsu Okumura 《World Journal of Gastroenterology》 SCIE CAS 2019年第36期5569-5577,共9页
BACKGROUND Intraductal papillary neoplasm of the bile duct (IPNB) is a type of tumor that presents in the intra- or extrahepatic bile ducts. Cystic-type intrahepatic IPNB often mimics simple liver cysts, making the di... BACKGROUND Intraductal papillary neoplasm of the bile duct (IPNB) is a type of tumor that presents in the intra- or extrahepatic bile ducts. Cystic-type intrahepatic IPNB often mimics simple liver cysts, making the diagnosis difficult. Because the growth of IPNB is slow, careful follow-up and timely therapeutic intervention is recommended. There are few reports with a follow-up period longer than a decade;thus, we report the case of a patient with an IPNB that grew for over 13 years. CASE SUMMARY A 65-year-old man was diagnosed, 13 years prior with a cystic hepatic tumor with abnormal imaging findings. The targeted tumor biopsy results showed no malignancy. Biannual follow-up examinations were performed because of the potential for malignancy. The cystic lesions showed gradual enlargement over 11 years and a 4 mm papillary proliferation appeared on the cyst wall, which is compatible with IPNB. The tumor was observed for another 2 years because of the patient’s wishes. The imaging findings showed enlargement to 8 mm and a new 9 mm papillary proliferation of the cystic tumor. Contrast-enhanced ultrasonography showed hyperenhancement during the arterial phase in both cyst walls, indicating intraductal tumor progression in both tumors. Thus, liver segment 8 subsegmentectomy was performed. The pathological findings indicated that the tumors contained mucin, and high-grade atypia was observed in the papillary lesions, showing IPNB.CONCLUSION The development of IPNB should be monitored in patients with cystic lesions and ultrasonography are useful tool for the evaluation. 展开更多
关键词 BILE duct NEOPLASM MUCIN Disease progression ULTRASONOGRAPHY Perfluorobutane Case report
下载PDF
Clinicopathological features of small nonfunctioning pancreatic neuroendocrine tumors
5
作者 Mariko Furukori koji imai +5 位作者 Hidenori Karasaki Kenji Watanabe Kensuke Oikawa Naoyuki Miyokawa Masahiko Taniguchi Hiroyuki Furukawa 《World Journal of Gastroenterology》 SCIE CAS 2014年第47期17949-17954,共6页
AIM:To present our experiences in studying the clinicopathological features of small nonfunctioning pancreatic neuroendocrine tumors(NF-p NETs).METHODS:The subjects included 9 patients with NFp NETs who underwent panc... AIM:To present our experiences in studying the clinicopathological features of small nonfunctioning pancreatic neuroendocrine tumors(NF-p NETs).METHODS:The subjects included 9 patients with NFp NETs who underwent pancreatectomy between April1996 and September 2012.The surgical procedure,histopathological findings,and prognosis were assessed.RESULTS:All tumors were incidentally detected by computed tomography.The median diameter was 10mm(5-32 mm).One patient was diagnosed with von Hippel-Lindau disease,and the others were sporadiccases.For the histopathological findings,7 patients were G1;1 patient was G2;and 1 patient,whose tumor was 22 mm,had neuroendocrine carcinoma(NEC).One patient who had a tumor that was 32 mm had direct invasion to a regional lymph node and 1 patient with NEC,had regional lymph node metastases.Six of the 7 patients with sporadic NF-p NETs,excluding the patient with NEC,had tumors that were smaller than10 mm.Tumors smaller than 10 mm showed no malignancy and lacked lymph node metastasis.CONCLUSION:Sporadic NF-p NETs smaller than 10mm tend to have less malignant potential.These findings suggest that lymphadenectomy may be omitted for small NF-p NETs after further investigation. 展开更多
关键词 PANCREATIC NEUROENDOCRINE TUMOR PANCREATIC neuroen
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部